Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vemurafenib Extension Study
NCT01739764Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2013
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 4 trial of vemurafenib in malignant neoplasm, sponsored by Roche. Started Feb 2013; status: completed.
02
Drugs
vemurafenib
03
Conditions
malignant neoplasm
Beyond the preview
Go deeper on NCT01739764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739764.